Clinical Trial Update: Rifaximin for Prevention of Travellers' Diarrhea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial updating rifaximin for prevention of travellers' diarrhea has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Traveller Diarrhea

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2019-12-18